T

Talkmed Group Ltd
SGX:5G3

Watchlist Manager
Talkmed Group Ltd
SGX:5G3
Watchlist
Price: 0.44 SGD -2.22% Market Closed
Market Cap: 584.2m SGD
Have any thoughts about
Talkmed Group Ltd?
Write Note

Talkmed Group Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Talkmed Group Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
T
Talkmed Group Ltd
SGX:5G3
Total Current Liabilities
S$24m
CAGR 3-Years
23%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Cordlife Group Ltd
SGX:P8A
Total Current Liabilities
S$32.7m
CAGR 3-Years
13%
CAGR 5-Years
-3%
CAGR 10-Years
5%
Q & M Dental Group (Singapore) Ltd
SGX:QC7
Total Current Liabilities
S$33.3m
CAGR 3-Years
3%
CAGR 5-Years
18%
CAGR 10-Years
12%
Healthway Medical Corporation Ltd
SGX:5NG
Total Current Liabilities
S$35.7m
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
-7%
HC Surgical Specialists Ltd
SGX:1B1
Total Current Liabilities
S$10.5m
CAGR 3-Years
11%
CAGR 5-Years
18%
CAGR 10-Years
N/A
EUDA Health Holdings Ltd
NASDAQ:EUDA
Total Current Liabilities
$8.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Talkmed Group Ltd
Glance View

Market Cap
583.7m SGD
Industry
Health Care

TalkMed Group Ltd. is an investment holding company, which engages in the provision of medical oncology, stem cell transplants, and palliative care services. The firm is a provider of medical oncology and palliative care health care services in Singapore. The firm operates through two segments: Oncology services, and Cellular and gene therapy related products and services. The Oncology services provide specialist doctors and clinical staff to Parkway Cancer Centre (PCC), a division of Parkway Hospitals Singapore Pte. Ltd. for the provision of specialist medical oncology services (consultancy services). The company also provides consultancy services to Thu Cuc International General Hospital (TCH), to enable TCH to operate a medical center for the provision of oncology services in Hanoi, Vietnam. The company also provides consultancy services to the patients in Beijing and Chongqing. Cellular and gene therapy-related products and services include the provision of goods and services related to cellular and gene therapy through its subsidiary, CellVec Pte. Ltd. (CellVec).

5G3 Intrinsic Value
0.31 SGD
Overvaluation 30%
Intrinsic Value
Price
T

See Also

What is Talkmed Group Ltd's Total Current Liabilities?
Total Current Liabilities
24m SGD

Based on the financial report for Jun 30, 2024, Talkmed Group Ltd's Total Current Liabilities amounts to 24m SGD.

What is Talkmed Group Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
10%

Over the last year, the Total Current Liabilities growth was 4%. The average annual Total Current Liabilities growth rates for Talkmed Group Ltd have been 23% over the past three years , 10% over the past five years .

Back to Top